Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) Obtains Registration Certificate for Concentrated Solution of Sodium Valproate for Injection
Yiping Red (300723.SZ) announced that its wholly-owned subsidiary Guangzhou Lianrui Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for its concentrated solution of sodium pentobarbital for injection.
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the concentrated solution of sodium butyrate injection.
This approval allows the company to sell the specified drug in the domestic market, expanding its product line and categories, and enhancing its competitiveness in the field of chronic disease medications.
Related Articles
GIANT BIOGENE (02367) spent HKD 14.3966 million to repurchase 400,000 shares on December 23rd.
Kuangda Technology Group (002516.SZ) plans to invest in establishing a subsidiary in Zhuzhou to undertake localized production and services in the region.
HYGEIA HEALTH (06078) spent HK$2.9993 million to repurchase 238,800 shares on December 23rd.
GIANT BIOGENE (02367) spent HKD 14.3966 million to repurchase 400,000 shares on December 23rd.
Kuangda Technology Group (002516.SZ) plans to invest in establishing a subsidiary in Zhuzhou to undertake localized production and services in the region.
HYGEIA HEALTH (06078) spent HK$2.9993 million to repurchase 238,800 shares on December 23rd.
RECOMMEND
